HIV 1 News and Research

RSS

LaeA gene shown to be an ideal prospect for new ways to fight infection

For the growing number of people with diminished immune systems - cancer patients, transplant recipients, those with HIV/AIDS - infection by a ubiquitous mold known as Aspergillus fumigatus can be a death sentence.

15 Apr 2007

The passing of 'honest sex education policy' applauded

Yesterday, the Washington State House of Representatives passed Senate Bill 5297 by a vote of 63-34, paving the way for comprehensive sex education -- education that includes scientifically accurate information on abstinence and the health benefits of birth control and condoms -- to be taught in the state's schools.

15 Apr 2007

New oral fluid-based HIV test shows great promise

A convenient, easy to use, and rapid alternative to blood-based HIV testing may become the new standard for field testing according to a new MUHC study.

12 Apr 2007

Analysis of Rhesus monkey genome provides new clues to primate biology

An international consortium of researchers has published the genome sequence of the rhesus macaque monkey and aligned it with the chimpanzee and human genomes.

12 Apr 2007

WHO welcomes decision by Abbott Labs to reduce price of lopinavir/ritonavir

The World Health Organization (WHO) is committed to work towards universal access, by 2010, to HIV prevention services and to treatment and care for people living with HIV/AIDS.

11 Apr 2007

AIDS Healthcare Foundation commends the passing of HIV testing bill

AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, prevention and education, and operator of the largest non-government HIV testing program in California which conducts more than 15,000 HIV tests annually, today lauded the California Assembly Health Committee for its unanimous vote (12/0) in favor of Assembly Bill 682, California's Routine HIV Screening Bill, which will now move on to the Assembly Appropriations Committee.

11 Apr 2007

Abbott agrees with WHO to expand access to lopinavir / ritonavir

Abbott and World Health Organization (WHO) Director-General, Margaret Chan, have agreed on a balanced approach to provide Kaletra/Aluvia (lopinavir/ritonavir) capsules and tablets to more patients in the developing world, while supporting continued long-term biopharmaceutical research and development.

10 Apr 2007

India is poised to revolutionize biotechnology

India's health biotech firms are emerging as a major global player, with growing means and know-how to produce innovative as well as generic drugs and vaccines at costs small relative to those of giant Western firms, according to ground-breaking Canadian research.

10 Apr 2007

Immunological catch-22 with chronic infections

After a viral infection, a small percentage of the T cells generated to kill virus-infected cells remain on guard to establish long-term immunity.

10 Apr 2007

New York City pushes for male circumcision to reduce spread of HIV

Officials in New York City are again at the forefront when it comes to health matters.

8 Apr 2007

UCLA research project targeting teens who leave home and their families

When emotions swell between teenager and parent, both sides sometimes say and do things they later wish they could take back.

7 Apr 2007

Chlamydia screening questioned

The value of opportunistic chlamydia screening is called into question in the British Medical Journal.

7 Apr 2007

$1.1 billion funding to low-income individuals living with HIV/AIDS in U.S.

HHS Secretary Mike Leavitt has announced more than $1.1 billion in funding to help states and territories provide care, medications and services for low-income individuals living with HIV/AIDS.

7 Apr 2007

Method for making new molecules based on flavonoids - implications for cancer therapeutics

You've heard of them -- the good-for-your-health compounds found in plants that we enjoy in red wine, dark chocolate, green tea and citrus fruits.

5 Apr 2007

Medical Services International receives increased interest in Dengue fever and Malaria test kits

Medical Services International Inc. has announced that the interest by regulatory authorities and the company's distributors has increased substantially for its VScan Dengue Fever and Malaria test kits.

5 Apr 2007

Multivitamin supplements improve birth outcomes among children born to HIV-negative women

Each year an estimated 20 million children are born with low birth weight worldwide, more than 95% of them in developing countries.

5 Apr 2007

CD4 Initiative to develop easy to use device that can measure CD4+ T-lymphocytes in HIV+ patients

Researchers at Rush University Medical Center have been selected to participate in a collaborative initiative to develop a simple, affordable and rapid test to measure the immune systems of people infected with HIV/AIDS in developing countries.

4 Apr 2007

FDA approves Twinrix

GlaxoSmithKline has announced that the U.S. Food and Drug Administration (FDA) has approved Twinrix [Hepatitis A Vaccine (Inactivated) and Hepatitis B (Recombinant) Vaccine], for an accelerated dosing schedule that consists of three doses given within three weeks followed by a booster dose at 12 months.

4 Apr 2007

Study suggests there's a role for religious institutions to play in the fight against HIV

HIV-positive people who say religion is an important part of their lives are likely to have fewer sexual partners and engage in high-risk sexual behavior less frequently than other people with the virus that causes AIDS, according to a study issued today by the RAND Corporation.

4 Apr 2007

Rabies vaccine approach against HIV shows promise

Rabies, a relentless, ancient scourge, may hold a key to defeating another implacable foe: HIV. Scientists at Jefferson Medical College in Philadelphia have used a drastically weakened rabies virus to ferry HIV-related proteins into animals, in essence, vaccinating them against an AIDS-like disease.

3 Apr 2007